ImmunoGen Inc IMGN:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/10/21 EDT
6.51quote price arrow down-0.82 (-11.19%)
Volume
2,243,029
52 week range
3.38 - 10.88

...

Loading . . .
  • Open6.97
  • Day High7.01
  • Day Low6.44
  • Prev Close6.51
  • 52 Week High10.88
  • 52 Week High Date02/12/21
  • 52 Week Low3.38
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap1.302B
  • Shares Out199.94M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change0.93

KEY STATS

  • Open6.97
  • Day High7.01
  • Day Low6.44
  • Prev Close6.51
  • 52 Week High10.88
  • 52 Week High Date02/12/21
  • 52 Week Low3.38
  • 52 Week Low Date09/04/20
  • Market Cap1.302B
  • Shares Out199.94M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change0.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.27
  • P/E (TTM)-23.69
  • Fwd P/E (NTM)-8.49
  • EBITDA (MRQ)-18.792M
  • ROE (MRQ)-659.86%
  • Revenue (MRQ)132.30M
  • Gross Margin (MRQ)76.15%
  • Net Margin (MRQ)-33.54%
  • Debt To Equity (MRQ)2.34%

EVENTS

  • Earnings Date07/29/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ImmunoGen Inc

There is no recent news for this security.

Profile

MORE
ImmunoGen, Inc. is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. An ADC with the Company's technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its product candidates include Mirvetuximab soravtansine; IMGN779; IMGN632; and Coltuximab ravtansine. Its...
Stephen McCluski
Chairman
Mark Enyedy J.D.
President
Susan Altschuller Ph.D.
Chief Financial Officer
Thomas Ryll Ph.D.
Vice President
Address
84 State St
Boston, MA
02109-2202
United States

Top Peers

SYMBOLLASTCHG%CHG
SGMO
Sangamo Therapeutics Inc
10.17-0.37-3.51%
RGNX
Regenxbio Inc
36.00-0.27-0.74%
TBIO
Translate Bio Inc
18.00-1.43-7.36%
DVAX
Dynavax Technologies Corp
7.90-1.91-19.47%
HRTX
Heron Therapeutics Inc
17.56+0.93+5.59%